In the past two years, Oncology Research has witnessed remarkable progress in the field of lung cancer research, with numerous innovative and prospective articles published between 2022 and 2023. From these we have carefully selected a range of papers covering different areas, including the diagnosis, treatment and prevention of lung cancer. By sharing these research breakthroughs, we aspire to provide readers with valuable insights and inspiration, fostering a deeper understanding of the ongoing advancements in lung cancer management.
The article is as follows：
01.High expression of PD-L1 mainly occurs in non-small cell lung cancer patients with squamous cell carcinoma or poor differentiation
https://www.techscience.com/or/v31n3/52819
02.Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells
https://www.techscience.com/or/v31n1/51751
03.Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany
https://www.techscience.com/or/v30n4/51395
04.The synergistic effects of PRDX5 and Nrf2 on lung cancer progression and drug resistance under oxidative stress in the zebrafish models
https://www.techscience.com/or/v30n2/51226
Thank you for your time.
Sincerely,
Oncology Research Editorial
There has been advances in systemic therapy against lung cancers but radiation therapy dose escalation has not shown much promise.
Investigation into radiosensitizers might be a good research question